Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Analysis of Communal Molecular Mechanism Between Chronic Obstructive Pulmonary Disease and Osteoporosis.

Tytuł:
Analysis of Communal Molecular Mechanism Between Chronic Obstructive Pulmonary Disease and Osteoporosis.
Autorzy:
Nie H; The First Clinical Medical College of Lanzhou University, Lanzhou, People's Republic of China.; Department of Gerontal Respiratory Medicine, the First Hospital of Lanzhou University, Lanzhou, People's Republic of China.
Wang F; The First Clinical Medical College of Lanzhou University, Lanzhou, People's Republic of China.
Zeng X; Department of Gerontal Respiratory Medicine, the First Hospital of Lanzhou University, Lanzhou, People's Republic of China.
Bao H; Department of Gerontal Respiratory Medicine, the First Hospital of Lanzhou University, Lanzhou, People's Republic of China.
Liu X; Department of Gerontal Respiratory Medicine, the First Hospital of Lanzhou University, Lanzhou, People's Republic of China.
Źródło:
International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2023 Mar 11; Vol. 18, pp. 259-271. Date of Electronic Publication: 2023 Mar 11 (Print Publication: 2023).
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: Auckland, N.Z. : DOVE Medical Press,
MeSH Terms:
MicroRNAs*/genetics
MicroRNAs*/metabolism
Osteoporosis*/diagnosis
Osteoporosis*/genetics
Pulmonary Disease, Chronic Obstructive*/diagnosis
Pulmonary Disease, Chronic Obstructive*/genetics
Humans ; Biomarkers ; Computational Biology ; Gene Expression Profiling ; Gene Regulatory Networks ; Quality of Life
References:
Ann N Y Acad Sci. 2006 Apr;1068:225-33. (PMID: 16831922)
J Inflamm Res. 2021 May 24;14:2173-2185. (PMID: 34079326)
Aging (Albany NY). 2020 Jun 2;12(11):10473-10487. (PMID: 32484789)
Arthritis Res Ther. 2007;9 Suppl 1:S1. (PMID: 17634140)
Biochem Pharmacol. 2021 Jun;188:114579. (PMID: 33895161)
Exp Cell Res. 2017 May 15;354(2):71-77. (PMID: 28327409)
Nucleic Acids Res. 2020 Jan 8;48(D1):D127-D131. (PMID: 31504780)
Science. 2019 Dec 20;366(6472):. (PMID: 31806698)
J Pharm Bioallied Sci. 2019 Oct-Dec;11(4):310-320. (PMID: 31619912)
Bone. 2017 Nov;104:29-38. (PMID: 28119181)
Int J Chron Obstruct Pulmon Dis. 2014 Jan 21;9:115-28. (PMID: 24489465)
Pharmacol Rev. 2016 Jul;68(3):788-815. (PMID: 27363440)
Am J Respir Cell Mol Biol. 2014 Mar;50(3):559-70. (PMID: 24111605)
Cell Mol Life Sci. 2019 Oct;76(19):3723-3744. (PMID: 31147752)
Bone. 2020 Aug;137:115350. (PMID: 32380256)
Cell Signal. 2020 Jun;70:109504. (PMID: 31857240)
Am J Respir Crit Care Med. 2019 Jan 1;199(1):P1-P2. (PMID: 30592446)
BMC Bioinformatics. 2014 Aug 29;15:293. (PMID: 25176396)
Zhonghua Yi Xue Za Zhi. 2016 Dec 13;96(46):3745-3750. (PMID: 27998433)
Cells. 2020 Sep 10;9(9):. (PMID: 32927921)
Nat Methods. 2015 Aug;12(8):697. (PMID: 26226356)
Cells. 2021 Dec 31;11(1):. (PMID: 35011694)
Eur Respir Rev. 2013 Mar 1;22(127):37-43. (PMID: 23457163)
Osteoporos Int. 2011 May;22(5):1451-8. (PMID: 20577873)
Oxid Med Cell Longev. 2021 Nov 15;2021:2896674. (PMID: 34820053)
Osteoporos Int. 2020 Apr;31(4):687-697. (PMID: 31811311)
Aging (Albany NY). 2015 Mar;7(3):205-18. (PMID: 25855145)
Connect Tissue Res. 2018 Mar;59(2):99-107. (PMID: 28324674)
J Bone Miner Res. 2010 Mar;25(3):463-71. (PMID: 19775203)
FASEB J. 2013 Feb;27(2):446-63. (PMID: 23085993)
Allergy. 2021 Jul;76(7):1967-1980. (PMID: 33314198)
Lancet. 2018 Apr 28;391(10131):1706-1717. (PMID: 29650248)
Chest. 2009 Dec;136(6):1456-1465. (PMID: 19581353)
Eur Respir J. 2019 Apr 25;53(4):. (PMID: 31023868)
J Pers Med. 2022 Oct 01;12(10):. (PMID: 36294765)
BMC Cancer. 2012 Oct 27;12:498. (PMID: 23101666)
Front Immunol. 2019 Apr 30;10:937. (PMID: 31134061)
Int J Cancer. 2014 Feb 15;134(4):961-70. (PMID: 23921845)
Clin Respir J. 2018 Feb;12(2):382-397. (PMID: 27925404)
Mol Diagn Ther. 2016 Dec;20(6):509-518. (PMID: 27378479)
Oncogene. 2004 Oct 18;23(48):7906-9. (PMID: 15489908)
Trends Cell Biol. 2015 Oct;25(10):601-610. (PMID: 26410406)
Nat Rev Mol Cell Biol. 2019 Jan;20(1):21-37. (PMID: 30108335)
Nat Rev Cancer. 2013 Apr;13(4):233-45. (PMID: 23467302)
Int J Chron Obstruct Pulmon Dis. 2018 Aug 01;13:2339-2349. (PMID: 30122914)
Nucleic Acids Res. 2021 Jan 8;49(D1):D605-D612. (PMID: 33237311)
Cell Biol Int. 2017 Mar;41(3):249-257. (PMID: 27981676)
Chest. 2019 Dec;156(6):1092-1110. (PMID: 31352034)
Biomed Res Int. 2019 Mar 7;2019:8214923. (PMID: 30956986)
Eur Respir J. 2009 Aug;34(2):380-6. (PMID: 19196816)
Sci Rep. 2018 Nov 1;8(1):16215. (PMID: 30385847)
Bioinformatics. 2017 Sep 15;33(18):2938-2940. (PMID: 28645171)
Int J Clin Exp Pathol. 2018 Nov 01;11(11):5257-5264. (PMID: 31949606)
Ann N Y Acad Sci. 2007 Nov;1116:360-75. (PMID: 18083938)
Expert Rev Respir Med. 2013 Aug;7(4):397-410. (PMID: 23952337)
Aging Clin Exp Res. 2022 Nov;34(11):2659-2674. (PMID: 35920994)
Respir Med. 2009 Aug;103(8):1143-51. (PMID: 19304474)
Cytokine Growth Factor Rev. 2021 Aug;60:18-27. (PMID: 33940443)
Curr Opin Pulm Med. 2008 Mar;14(2):122-7. (PMID: 18303421)
Bone. 2016 Feb;83:94-103. (PMID: 26545336)
Cell Prolif. 2019 Nov;52(6):e12688. (PMID: 31557368)
Contributed Indexing:
Keywords: bioinformatics; chronic obstructive pulmonary disease; microRNA; osteoporosis
Substance Nomenclature:
0 (Biomarkers)
0 (MicroRNAs)
Entry Date(s):
Date Created: 20230320 Date Completed: 20230327 Latest Revision: 20230628
Update Code:
20240105
PubMed Central ID:
PMC10017835
DOI:
10.2147/COPD.S395492
PMID:
36937804
Czasopismo naukowe
Background: Chronic obstructive pulmonary disease (COPD) patients with osteoporosis (OP) usually experience more frequent exacerbations, worse quality of life, and heavier economic burden, however, few studies have investigated common molecular mechanisms of COPD and OP.
Objective: To explore the relationship between COPD and OP through bioinformatics analysis.
Methods: The miRNA microarray data of COPD and OP were retrieved from the Gene Expression Database (GEO), and the differentially expressed microRNAs (DEmiRNAs) were screened and the intersection was obtained. The Targetscan, miRDB, and miRWalk databases were used to predict the target genes of DEmiRNA, and the gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed using the R package clusterProfiler, the STRING database was used to analyze the target protein-protein interaction network (PPI) and screens to determine the core modules and core genes.
Results: Two DEmiRNAs (miR-23a-5p, miR-194-3p) have been found in COPD and OP, which have predicted 76 and 114 target genes, respectively. GO functional annotations of miR-23a-5p were significantly enriched in CD40 signaling pathway, ubiquitin-conjugating enzyme activity, etc; KEGG pathways of miR-23a-5p were significantly enriched in ubiquitin-mediated proteolysis, folate biosynthesis, and regulation of actin cytoskeleton. GO function annotations of miR-194-3p were significantly enriched in T cell activation regulation, ubiquitin protein ligase activity, and DNA transcription factor binding; KEGG pathways of miR-194-3p were significantly enriched in cell adhesion molecules, intercellular tight junctions, and lysosomal pathway. PPI analysis found target coding proteins formed complex regulatory networks. Ten core genes ( TP53 , SRC , PXN , CHD4 , SYK , TNRC6B , PML , KAT5 , BRD1 and IGF2 ) were picked out among them, then we used the MCODE plugin found three core subnetworks.
Conclusion: Two identical DEmiRNAs (miR-23a-5p, miR-194-3p) exist in the peripheral blood of COPD and OP patients, which are important biomarkers for COPD patients with OP and may represent novel targets for diagnosis and treatment of COPD patients with OP.
Competing Interests: The authors have no conflicts of interest to declare.
(© 2023 Nie et al.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies